Home » Stocks » OM

Outset Medical, Inc. (OM)

Stock Price: $49.53 USD -0.69 (-1.37%)
Updated Feb 25, 2021 3:59 PM EST - Market closed
After-hours: $49.57 +0.04 (0.08%) Feb 25, 4:00 PM
Market Cap 2.09B
Revenue (ttm) 39.77M
Net Income (ttm) -108.89M
Shares Out 12.30M
EPS (ttm) -8.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $49.53
Previous Close $50.22
Change ($) -0.69
Change (%) -1.37%
Day's Open 50.26
Day's Range 48.00 - 51.00
Day's Volume 117,928
52-Week Range 42.50 - 66.96

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 month ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysi...

Other stocks mentioned: RMD
The Motley Fool - 2 months ago

Discover how Outset Medical is making dialysis easier and cheaper.

Business Wire - 2 months ago

LONDON--(BUSINESS WIRE)--Deep Pharma Intelligence names Nanox Imaging (NASDAQ:NNOX), TransMedics, Inc. (NASDAQ: TMDX), Outset Medical, Inc. (NASDAQ:OM), Eargo, Inc. (NASDAQ:EAR), and Silk Road...

Other stocks mentioned: EAR, NNOX, SILK, TMDX
Business Wire - 2 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...

Business Wire - 2 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical Announces Secondary Offering of Common Stock

Seeking Alpha - 2 months ago

Outset Medical is performing in line with my expectations which I outlined at the time of the public offering. I look forward to the contribution from the home market in 2021, expected to have...

Business Wire - 3 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...

Business Wire - 3 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...

Business Wire - 3 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...

Business Wire - 3 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...

Business Wire - 4 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dia...

Seeking Alpha - 5 months ago

Outset Medical: Very Interesting MedTech Growth Play

Business Wire - 5 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc.

Business Wire - 5 months ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”) today announced the pricing of its upsized initial public offering of 8,951,111 shares of its common stock at a ...

About OM

Outset Medical, a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo, a dialysis machine that enables dialysis care in acute and chronic settings. The Tablo comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Industry
Medical Devices
IPO Date
Sep 15, 2020
CEO
Leslie L. Trigg
Employees
284
Stock Exchange
NASDAQ
Ticker Symbol
OM
Full Company Profile

Financial Performance

In 2019, Outset Medical's revenue was $15.08 million, an increase of 651.27% compared to the previous year's $2.01 million. Losses were -$68.30 million, 37.2% more than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Outset Medical stock is "Buy." The 12-month stock price forecast is 58.40, which is an increase of 17.91% from the latest price.

Price Target
$58.40
(17.91% upside)
Analyst Consensus: Buy